|
|
|
| Organ and Tissue Transplantation and Alternatives |
|
| Table of Contents Published: 2008/10 Published by: BCC Research |
| This report offers forecasts by product segment from 2008 through 2013, including supporting analyses for projections. Product segments covered consist of solid organs (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation ... |
| Gene Silencing Dashboard: Series Two |
|
| Table of Contents Published: 2008/09 Published by: Percepta Associates Inc. |
| RNA interference continues to emerge as a integral tool used to study the physiological role of gene products in vivo. RNAi-based methods allow researchers to modulate and in many cases virtually eliminate expression of a gene of interest. Systems for del ... |
| Biotechnology |
|
| Table of Contents Published: 2008/09 Published by: Global Industry Analysts, Inc. |
| The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird' s eye view of the Biotechnology industry. Annotated with 26 fact, and data rich ... |
| Global Antivirals Market Analysis & Forecasts 2008-2023 |
|
| Table of Contents Published: 2008/09 Published by: Visiongain |
| Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs ... |
| Stem Cells in Regenerative Medicine 2008 Market Report |
|
| Table of Contents Published: 2008/09 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space. ... |
| U.S. Stem Cell Market - Current Developments |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research service covers the U.S. stem cell market: current developments. Included are a disease overviews for main indications, estimated patient penetration for main indications, technology trends,and total market potential. The market is segmented ... |
| Who's Developing What in Global Biopharmaceuticals? |
|
| Table of Contents Published: 2008/09 Published by: Espicom Business Intelligence |
| The biopharmaceutical R&D sector is taking an ever more important role in the minds of industry and investors. The potential to fundamentally alter treatment regimes and cure, rather than symptomatically treat, many life-threatening conditions grows great ... |
| European Biosimilars Market Outlook |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing m ... |
| U.S. Nucleic Acid Purification and Isolation Markets |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research service analyzes the market for nucleic acid purification and isolation products within the United States. The market was divided into the nucleic acid purification and isolation consumables and nucleic acid purification and isolation instru ... |
| Cancer Drug Resistance 2008 |
|
| Table of Contents Published: 2008/09 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This new report includes i) A Global Resistance Map: a presentation and review of resistance mechanisms or resistance-associated changes at the gene, protein or functional level reported for currently approved cancer drugs, covering 60 general cancer drug ... |
| Microarray Markets |
|
| Table of Contents Published: 2008/09 Published by: Trimark Publications |
| A microarray is an arrangement of miniaturized test sites or spots on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the ... |
| Discovery Stage Partnering Agreements in Biopharma |
|
| Table of Contents Published: 2008/09 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Discovery Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies. ... |
| Biomarkers: The Future of Next-Generation Drug R&D |
|
| Table of Contents Published: 2008/09 Published by: Takeda Pacific |
| This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools ... |
| Molecular Diagnostics Markets |
|
| Table of Contents Published: 2008/09 Published by: Trimark Publications |
| The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels-a ... |
| Global Biotech Market Analysis and Forecasts, 2008-2023 |
|
| Table of Contents Published: 2008/08 Published by: Visiongain |
| The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has ... |
| US Markets for Orthopedic Biomaterials |
|
| Table of Contents Published: 2008/08 Published by: iData Research Inc. |
| In 2007, the orthopedic biomaterials market was valued at over $2.6 billion, growing at an associated CAGR of 12.9% by 2014.There is great promise in the future performance of the orthopedic biomaterials market. To date there has been a multitude of produ ... |
| CNS Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The CNS biomarker market represents one of the smallest segments of biomarkers in terms of revenue as relatively few CNS biomarkers are commercially available. In 2007, we estimate the CNS biomarker market accounted for less than 5% of biomarker revenues, ... |
| Cancer Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The cancer biomarker market represents one of the largest segments of biomarkers in terms of revenue. In 2007, the estimated cancer biomarker market accounted for around 55% of biomarker revenues at over US$3 billion, with the majority of revenues derived ... |
| Lessons Learned from the Current Crop of Biotech Startups |
|
| Table of Contents Published: 2008/08 Published by: Decision Resources, Inc. |
| The initial public offering (IPO) market for biotech and specialty pharma companies has been nearly lifeless in 2008. Investment bankers are unimpressed by the performance of these companies, and money managers are reluctant to support a negative trend. T ... |
| Biosimilars Series: Stakeholder Analysis |
|
| Table of Contents Published: 2008/08 Published by: Datamonitor |
| Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers critical to the initial rate of uptake. The opinion of key stakeholders, and the influence they wield, will therefore infor ... |
| DNA Sequencing: Emerging Technologies and Applications |
|
| Table of Contents Published: 2008/08 Published by: BCC Research |
| The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact o ... |
| Therapeutic Monoclonal Antibodies Report 2008-2023 |
|
| Table of Contents Published: 2008/07 Published by: Visiongain |
| This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, thinner pipelines than before and pressure from an ever-aggressive generics ind ... |
|
|
|
View Cart
Top